Chiral Alkyl Halides: Underexplored Motifs in Medicine

Carey, F.A., and Sundberg, R.J. (2007). Advanced Organic Chemistry, Part B: Reaction and Synthesis, Springer. [5th ed.].

Kambe, 2011, Pd-catalyzed cross-coupling reactions of alkyl halides, Chem. Soc. Rev., 40, 4937, 10.1039/c1cs15129k

Nicolaou, 2006, Cascade Reactions in Total Synthesis, Angew. Chem. Int. Ed., 45, 7134, 10.1002/anie.200601872

Los, 2008, HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis, ACS Chem. Biol., 3, 373, 10.1021/cb800025k

Frang, 2001, Phenoxybenzamine Binding Reveals the Helical Orientation of the Third Transmembrane Domain of Adrenergic Receptors, J. Biol. Chem., 276, 31279, 10.1074/jbc.M104167200

WHO Model List of Essential Medicines. Available online: http://www.who.int/medicines/publications/essentialmedicines/en/index.html.

Smith, 1999, Pharmacokinetics and metabolism in early drug discovery, Curr. Opin. Chem. Biol., 3, 373, 10.1016/S1367-5931(99)80056-8

Gerebtzoff, 2004, Halogenation of Drugs Enhances Membrane Binding and Permeation, ChemBioChem, 5, 676, 10.1002/cbic.200400017

Gentry, 1999, The effect of halogenation on blood-brain barrier permeability of a novel peptide drug, Peptides, 20, 1229, 10.1016/S0196-9781(99)00127-8

Xu, 2014, Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development, J. Chem. Inf. Model., 54, 69, 10.1021/ci400539q

Gillis, 2015, Applications of Fluorine in Medicinal Chemistry, J. Med. Chem., 58, 8315, 10.1021/acs.jmedchem.5b00258

Franks, 2008, General Anaesthesia: From Molecular Targets to Neural Pathways of Sleep and Arousal, Nat. Rev. Neurosci., 9, 370, 10.1038/nrn2372

Franks, 1991, Stereospecific Effects of Inhalational General Anesthetic Optical Isomers on Nerve Ion Channels, Science, 254, 427, 10.1126/science.1925602

Liu, 2005, Structural Bases for High-Affinity Volatile Anesthetic Binding in a Natural 4-Helix Bundle Protein, FASEB J., 19, 567, 10.1096/fj.04-3171com

Cavallo, 2016, The halogen bond, Chem. Rev., 116, 2478, 10.1021/acs.chemrev.5b00484

Parisini, 2011, Halogen bonding in halocarbon-protein complexes: A structural survey, Chem. Soc. Rev., 40, 2267, 10.1039/c0cs00177e

Clindamycin Hydrochloride. Available online: https://www.drugs.com/monograph/clindamycin-hydrochloride.html.

Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H., and Waring, M.J. (1981). The Molecular Basis of Antibiotic Action, John Wiley & Sons. [2nd ed.].

1985, Structure Activity Relationships in Lincosamide and Streptogramin Antibiotics, J. Antimicrob. Chemother., 16, 13, 10.1093/jac/16.suppl_A.13

Douthwaite, 1992, Interaction of the Antibiotics Clindamycin and Lincomycin with Escherichia coli 23S Ribosomal RNA, Nucleic Acids Res., 20, 4717, 10.1093/nar/20.18.4717

Zarivach, 2001, Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria, Nature, 413, 814, 10.1038/35101544

Barnes, 1999, Therapeutic strategies for allergic diseases, Nature, 402, B31, 10.1038/35037026

Kumar, 1999, The structure of the nuclear hormone receptors, Steroids, 64, 310, 10.1016/S0039-128X(99)00014-8

Kohn, 2012, Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors, J. Biol. Chem., 287, 16267, 10.1074/jbc.M112.346411

Wolff, 1978, Nature of steroid-glucocorticoid receptor interactions: Thermodynamic analysis of the binding reaction, Biochemistry, 17, 3201, 10.1021/bi00609a005

Buchwald, 2008, Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp mode, Steroids, 73, 193, 10.1016/j.steroids.2007.10.001

Allen, 2003, Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients, Arch. Dis. Child., 88, 969, 10.1136/adc.88.11.969

Weiss, 2008, Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application, Drug Metab. Dispos., 336, 1812, 10.1124/dmd.108.021915

Knight, 1994, The development and applications of sucralose, a new high-intensity sweetener, Can. J. Physiol. Pharmacol., 72, 435, 10.1139/y94-063

Roberts, 2000, Sucralose metabolism and pharmacokinetics in man, Food Chem. Toxicol., 38, S31, 10.1016/S0278-6915(00)00026-0

Schallenberger, 1967, Molecular theory of sweet taste, Nature, 216, 480, 10.1038/216480a0

Schallenberger, 1969, Molecular structure and sweet taste, J. Acric. Food Chem., 17, 701, 10.1021/jf60164a032

Kier, 1972, Molecular theory of sweet taste, J. Pharm. Sci., 61, 1394, 10.1002/jps.2600610910

Newman, 2016, Natural Products as Sources of New Drugs from 1981 to 2014, J. Nat. Prod., 79, 629, 10.1021/acs.jnatprod.5b01055

Gribble, 2015, Biological Activity of Recently Discovered Halogenated Marine Natural Products, Mar. Drugs, 13, 4044, 10.3390/md13074044

Burreson, 1975, Evidence for the biogenesis of halogenated myrcenes from the red alga Chondrococcus hornemanni, Chem. Lett., 4, 1111, 10.1246/cl.1975.1111

Fuller, 1992, A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines, J. Med. Chem., 35, 3007, 10.1021/jm00094a012

Fuller, 1994, Isolation and Structure/Activity Features of Halomon-Related Antitumor Monoterpenes from the Red Alga Portieria hornemannii, J. Med. Chem., 37, 4407, 10.1021/jm00051a019

Andrianasolo, 2006, DNA Methyl Transferase Inhibiting Halogenated Monoterpenes from the Madagascar Red Marine Alga Portieria hornemannii, J. Nat. Prod., 69, 576, 10.1021/np0503956

Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm, J. Natl. Cancer Inst., 81, 1088, 10.1093/jnci/81.14.1088

Bucher, 2015, Highly Selective Synthesis of Halomon, Plocamenone, and Isoplocamenone, J. Am. Chem. Soc., 137, 12784, 10.1021/jacs.5b08398

Bucher, C., Valeriote, F.A., and Burns, N.Z. (2016). Unpublished work.

Guiraud, 1994, Comparison of Antibacterial and Antifungal Activities of Lapachol and β-Lapachone, Planta Med., 60, 373, 10.1055/s-2006-959504

Ravelo, 2005, Antiplasmodial Activity of Naphthoquinones Related to Lapachol and β-Lapachone, Chem. Biodivers., 2, 264, 10.1002/cbdv.200590009

Goulart, 2004, Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo, Bioorg. Med. Chem. Lett., 14, 1145, 10.1016/j.bmcl.2003.12.069

Pardee, 2002, Cancer therapy with β-lapachone, Curr. Cancer Drug Targets, 2, 224, 10.2174/1568009023333854

Ravelo, 2007, Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line, J. Med. Chem., 50, 696, 10.1021/jm060849b

Morita, 1996, Cyclic peptides from higher plants. XXVIII. Antitumor activity and hepatic microsomal biotransformation of cyclic pentapeptides, astins, from Aster tataricus, Chem. Pharm. Bull., 5, 1026, 10.1248/cpb.44.1026

Wyche, 2014, Forazoline A: marine-derived polyketide with antifungal in vivo efficacy, Angew. Chem. Int. Ed. Engl., 53, 11583, 10.1002/anie.201405990